Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 28, 2020; 26(4): 375-382
Published online Jan 28, 2020. doi: 10.3748/wjg.v26.i4.375
Published online Jan 28, 2020. doi: 10.3748/wjg.v26.i4.375
Table 2 Proposed goals of future patient-centered research on neoadjuvant therapy for pancreatic ductal adenocarcinoma
| Patient preferences |
| What are patient perceptions and opinions regarding NT? |
| What are the barriers and facilitators to NT? |
| What sources of information inform decision making for NT? |
| The patient experience |
| How does shared decision making occur regarding NT? |
| How do patients perceive communication, coordination, and the health care experience during NT? |
| What resources are needed by patients undergoing NT? |
| Patient-reported outcomes (PROs) |
| Are PROs for pancreatic cancer similar or unique during NT? |
| How is patient quality of life affected by NT? |
| Survivorship |
| Does receipt of NT influence survivorship during and following treatment? |
| Do patients experience decisional regret/satisfaction? |
- Citation: Cloyd JM, Tsung A, Hays J, Wills CE, Bridges JF. Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research. World J Gastroenterol 2020; 26(4): 375-382
- URL: https://www.wjgnet.com/1007-9327/full/v26/i4/375.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i4.375